New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society of Nuclear Medicine and Molecular Imaging, an international scientific and ...
Liv Hospital integrates PET/CT diagnostics, radionuclide therapies and a multidisciplinary council to create individualized treatment plans for complex cancer and cardiac cases.
ZME Science on MSN
Aspartame Is Marketed as a Safer Sugar Swap But New Research Shows Long Term Low Doses May Strain the Brain and Heart
A year-long experiment raises new doubts about the safety limits of one of the most popular artificial sweeteners.
Fitgurú on MSN
New study raises alarms about aspartame: Long-term use may affect brain and heart health
A year-long experiment found that even low doses of aspartame—well below current safety limits—may disrupt brain energy use ...
New research has been published ahead-of-print by The Journal of Nuclear Medicine (JNM). JNM is published by the Society ...
In this exclusive MedPage Today video, Specht is joined via Zoom by study co-lead, Heather Jacene, MD, of Brigham and Women's ...
Researchers compared a traditional Chinese medicine, Yueju Pill, with a standard antidepressant and found both reduced ...
At the Yale Positron Emission Tomography (PET) Center, an ultra-high-performance brain-dedicated scanner called the NeuroEXPLORER (NX) is redefining what is possible in brain PET imaging. With a ...
SynuSight Biotech has licensed 18 F-FD4 to XingImaging and to ABLi Therapeutics to evaluate alpha-synuclein clearance from the brain in response to risvodetinib treatment . SHANGH ...
A brain-dedicated scanner is changing what doctors can see. CT researchers say that ‘opens the door’
The ability to follow patients with this high sensitivity allows us to make a more accurate and precise measurement, and we can see small changes or see them in a shorter period of time…,” ...
American Century Focused Dynamic Growth ETF (FDG) is rated Buy for its consistent outperformance versus the Russell 1000 Growth ETF and SPY. FDG’s concentrated portfolio of 30–45 high-growth companies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results